Related Experiment Video
Updated: May 11, 2026

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
Caffeine eye drops protect against UV-B cataract.
Martin Kronschläger1, Stefan Löfgren, Zhaohua Yu
1Gullstrand Lab., Ophthalmology, Dept. of Neuroscience, Uppsala University, Sweden. martin.kronschlager@neuro.uu.se
Topical caffeine application offers protection against UV-B radiation-induced cataracts in rats. This study found caffeine reduced cataract formation, demonstrating its potential as a protective agent for the eyes.
Area of Science:
- Ophthalmology
- Photobiology
- Pharmacology
Background:
- Ultraviolet (UV) radiation exposure is a known risk factor for cataract development.
- The potential protective effects of topical agents against UV-induced ocular damage require further investigation.
Purpose of the Study:
- To determine if topically applied caffeine can prevent or mitigate UV-B radiation-induced cataracts in vivo.
- To quantify the protective factor of caffeine against UV-B damage to the lens.
Main Methods:
- Sprague-Dawley rats received topical placebo or caffeine eye drops before unilateral UV-B exposure.
- Cataract formation was assessed by measuring lens light scattering and glutathione (GSH) levels.
- Immunohistochemistry was used to detect activated caspase-3, a marker of apoptosis.
Main Results:
- Caffeine treatment significantly reduced UV-B-induced cataract formation compared to placebo.
- A protection factor of 1.23 was estimated for caffeine.
- No significant difference in lens GSH levels was observed between groups.
- Reduced caspase-3 activation was noted in UV-B-exposed lenses from the caffeine group.
Conclusions:
- Topical caffeine demonstrates a protective effect against UV-B radiation-induced cataracts.
- Caffeine appears to mitigate UV-B damage by reducing lens cell apoptosis.
Related Concept Videos
Photoreceptors and Visual Pathways
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Accessory Structures of the Eye

